Cormorant Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $50.2M | Sell |
|
|||||
|
2020
Q2 | $50.3M | Sell |
|
|||||
|
2020
Q1 | $53.9M | Buy |
|
|||||
|
2019
Q4 | $28.4M | Sell |
|
|||||
|
2019
Q3 | $19.4M | Sell |
|
|||||
|
2019
Q2 | $17.2M | Buy |
|
|||||
|
2019
Q1 | $11.9M | Buy |
|
|||||
|
2018
Q4 | $5.31M | Hold |
|
|||||
|
2018
Q3 | $3.85M | Hold |
|
|||||
|
2018
Q2 | $7.46M | Buy |
|